Deadline: 12-Apr-2024
The Foundation for Liver Research is currently accepting applications for the Legacy Grants Scheme.
The main aim of this translational research programme is to support experimental studies in the following key areas:
- Improved understanding of the pathogenesis of liver disease
- The development of accurate diagnostic tests, identification of early risk biomarkers, and exploration of protective and therapeutic vaccination strategies for liver disease.
- Accelerated translation of research discoveries from bench-to-bedside
The overarching purpose of the scheme is to enable translational research that tangibly benefits patients with liver disease. It is expected that this pump-prime award would support the acquisition of preliminary data, fostering the foundations for a subsequent application to a Research Council or a similar funding body for a programme grant or fellowship award. They hope that this funding will ultimately culminate in grant success, peer-reviewed publications and significant clinical advancements in the understanding and treatment of liver diseases.
In 2024, they particularly encourage proposals for innovative translational studies that delve into the molecular intricacies governing the cross-talk between fat and alcohol in Metabolic Alcohol-Related Liver Disease (MetALD). Understanding the molecular underpinnings of this complex interaction is crucial for developing targeted interventions. Proposals should aim to uncover molecular pathways, biomarkers, and potential therapeutic targets associated with the interplay of fat and alcohol, to advance their understanding of the molecular landscape in MetALD, paving the way for novel therapeutic strategies and personalised treatment approaches.
Funding Information
- The Foundation invites applications for awards of up to £50,000 towards the direct costs of the project (note that service delivery, educational events, commercial studies, major equipment, overheads and indirect costs will not be funded).
- Projects must be between 12-24 months in duration and project must start between 1st July 2024 and 1st January 2025.
Eligibility Criteria
- Applicants, projects and the host institution must be based in UK organisations.
- Applications must be within the scope of the above outlined Call for Applications (e.g. no social science projects, or projects not relating specifically to liver disease).
- Prior recipients of this funding scheme are not eligible to apply for further grants.
- Resubmission of previous applications are only accepted for proposals which scored highly in previous rounds (22 or above in 2023).
- Staff and students at The Roger Williams Institute of Hepatology are not eligible to apply.
For more information, visit Foundation for Liver Research.
